Levotiron 50 Abdi Ibragim — Research Summary
Levotiron 50 Abdi Ibrahim is a pharmaceutical-grade L-thyroxine sodium (levothyroxine sodium, LT4 sodium) compound manufactured for in-vitro laboratory research applications. L-thyroxine sodium represents the synthetic form of the naturally occurring thyroid hormone thyroxine (T4), serving as a critical research tool for investigating thyroid hormone receptor pathways, metabolic regulation mechanisms, and cellular energy homeostasis in controlled laboratory environments.
Researchers at Stroid UK Shop utilize L-thyroxine sodium preparations to examine the molecular mechanisms underlying thyroid hormone signalling, including receptor binding kinetics, gene transcription modulation, and downstream metabolic effects in cellular and tissue culture systems. This pharmaceutical-grade formulation provides consistent potency for reproducible experimental outcomes across metabolic research protocols.
Laboratory Applications
L-thyroxine sodium serves as an essential compound for studying thyroid hormone receptor biology, metabolic pathway regulation, and cellular energy expenditure mechanisms. Research applications include investigation of T4 to T3 conversion pathways via deiodinase enzymes, examination of thyroid hormone receptor alpha and beta isoform selectivity, and analysis of transcriptional regulation in metabolic gene expression studies.
Laboratory investigations frequently examine L-thyroxine sodium’s effects on mitochondrial biogenesis, oxidative metabolism pathways, and thermogenesis regulation in cellular models. Researchers studying fat burner compounds often incorporate L-thyroxine sodium as a reference standard for comparing metabolic modulation effects. Additional research focuses on cardiovascular tissue responses, skeletal muscle metabolism, and hepatic glucose production mechanisms in controlled experimental systems.
Advanced metabolic research protocols examine interactions between L-thyroxine sodium and other compounds, including SARMs research chemicals and peptide modulators, to understand synergistic effects on cellular energy homeostasis and tissue-specific metabolic responses.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | L-Thyroxine Sodium (LT4 Sodium) |
| Strength | 50 mcg per tablet |
| Manufacturer | Abdi Ibrahim |
| CAS Number | 55-03-8 |
| Molecular Formula | C₁₅H₁₀I₄NNaO₄ |
| Molecular Weight | 798.85 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Compliance Statement
Levotiron 50 Abdi Ibrahim is manufactured exclusively for in-vitro research applications and laboratory investigation purposes. This product is not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines for handling pharmaceutical compounds. All studies involving L-thyroxine sodium must be conducted under proper research supervision with appropriate analytical verification methods.
